Sign inJoin waitlistJoin the waitlist

RS

Ravi Salgia

Physician · City of Hope

Credentials: · · · · ·

History

City of Hope
Present

Medical Oncology
1988–1990
Internal Medicine
1985–1988
Loyola University Chicago Stritch School of Medicine
1981–1985

Research

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
New England Journal of Medicine · 2010 · 3,649 citations
Crizotinib in ROS1-rearranged non-small-cell lung cancer
New England Journal of Medicine · 2014 · 1,560 citations
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Review · Journal for ImmunoTherapy of Cancer · 2018 · Last of 4 authors · Corresponding · 1,025 citations

Everett Vokes
47 papers
EM
Erminia Massarelli
41 papers
James Griffin
39 papers
Aliya Husain
36 papers
Arya Amini
36 papers · 1 as a resident
EP
Evan Pisick
28 papers · 7 as a resident
Patrick Ma
26 papers
VV
Victoria Villaflor
24 papers
Maria Tretiakova
23 papers · 15 as a resident
SA
Sanjay Awasthi
22 papers
SB
Surinder Batra
19 papers
Hedy Kindler
18 papers

Grants

Cooperation of the TAM and Abl Family Kinases in Therapeutic Resistance in HNC
National Cancer Institute · R01
PI · $2.9M · University of Wisconsin-Madison
2022–2027
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
National Cancer Institute · R01
PI · $2.8M · University of Nebraska Medical Center
2019–2026
Role of Paxillin in Lung Cancer
National Cancer Institute · R01
Contact PI · $1.8M · University of Chicago
2008–2014
Cytoskeletal Regulation of Lung Endothelial Pathobiology
National Heart, Lung, and Blood Institute · P01
Project lead · $1.7M · University of Illinois at Chicago
2008–2014

Clinical trials

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
2026–2028
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
Principal investigator · Recruiting · Phase 1
City of Hope Medical Center
2024–2026
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
Principal investigator · Active not recruiting · Phase 1
HUYABIO International, LLC.
2021–2026
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Principal investigator · Suspended · Phase 1
City of Hope Medical Center
2021–2027